急性肾损伤治疗48小时应答与否对HBV相关慢加急性肝衰竭短期预后的影响

翟兴冉; 许祥; 陈婧; 穆秀颖; 童晶晶; 苏海滨; 刘晓燕; 关崇丹; 王宇; 胡瑾华

doi:10.3969/j.issn.1001-5256.2019.09.023

急性肾损伤治疗48小时应答与否对HBV相关慢加急性肝衰竭短期预后的影响

DOI: 10.3969/j.issn.1001-5256.2019.09.023

1. 北京大学三〇二临床医学院
2. 解放军总医院第五医学中心肝衰竭诊疗与研究中心
3. 解放军医学院

基金项目:

第三○二医院院长创新基金资助项目(KIGG2015001)；

详细信息

中图分类号: R575.3;R692;R512.62
计量
- 文章访问数: 1246
- HTML全文浏览量: 49
- PDF下载量: 231
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-10
- 出版日期: 2019-09-20

Effect of response at 48 hours of treatment of acute kidney injury on short-term prognosis of hepatitis B virus-associated acute-on-chronic liver failure

Peking University 302 Clinical Medical School

Research funding:

摘要

摘要:
目的探讨HBV相关慢加急性肝衰竭（HBV-ACLF）合并急性肾损伤（AKI）患者AKI治疗48 h应答与否对其28 d和90 d预后的影响。方法回顾性分析2012年12月-2014年12月在解放军总医院第五医学中心住院治疗的130例HBV-ACLF合并AKI患者的临床资料,根据AKI治疗48 h的情况分为应答组和无应答组,比较2组患者28 d和90 d生存率,进而筛选28 d和90 d预后独立影响因素。符合正态分布的计量资料2组间比较采用t检验;不符合正态分布的计量资料2组间比较采用Kolmogorow-Smirnov Z秩和检验。计数资料2组间比较则采用χ2检验。采用Kaplan-Meier生存曲线分析2组患者的生存率,并应用logrank检验进行比较。采用Cox回归风险模型进行预后影响因素的单因素及多因素分析。结果 AKI治疗48 h应答组38例（29. 2%）,无应答组92例（70. 8%）。无应答组28 d和90 d生存率均低于应答组（χ2值分别为16. 91、23. 28,P值均<0. 01）。Cox回归分析显示,AKI治疗48 h应答、年龄、血清肌酐、血清钠、INR、...
- 肝功能衰竭 /
- 乙型肝炎病毒 /
- 急性肾功能不全 /
- 治疗结果 /
- 预后
Abstract:
Objective To investigate whether response to the treatment of acute kidney injury ( AKI) is achieved at 48 hours and its effect on the 28-and 90-day prognosis of patients with hepatitis B virus-associated acute-on-chronic liver failure ( HBV-ACLF) and AKI.Methods A retrospective analysis was performed for the clinical data of 130 patients with HBV-ACLF and AKI who were hospitalized and treated in The Fifth Medical Center of Chinese PLA General Hospital from December 2012 to December 2014. According to the response to AKI treatment at 48 hours, the patients were divided into response group and non-response group, and the two groups were compared in terms of 28-and 90-day survival rates to screen out the independent influencing factors for 28-and 90-day prognosis. The t-test was used for comparison of normally distributed continuous data between two groups, and the Kolmogorov-Smirnov Z test was used for comparison of non-normally distributed continuous data between two groups. The chi-square test was used for comparison of categorical data between two groups. The Kaplan-Meier survival curve was used to analyze survival rate, and the log-rank test was used for comparison. The Cox regression model was used to perform the univariate and multivariate analyses of influencing factors for prognosis. Results There were38 patients ( 29. 2%) in the response group and 92 patients ( 70. 8%) in the non-response group. The non-response group had significantly lower 28-and 90-day survival rates than the response group ( χ2= 16. 91, 23. 28, both P < 0. 01) . The Cox regression analysis showed that response to AKI treatment at 48 hours, age, serum creatinine, serum sodium, international normalized ratio, and hepatic encephalopathy were independent risk factors for 28- ( HR ( 95% CI) = 0. 271 ( 0. 116-0. 631) , 1. 024 ( 1. 001-1. 047) , 1. 002 ( 1. 000-1. 005) , 0. 948 ( 0. 904-0. 993) , 1. 451 ( 1. 139-1. 849, 1. 987 ( 1. 076-3. 670) , all P < 0. 05) and 90-day ( HR ( 95% CI) = 0. 292 ( 0. 151-0. 563) , 1. 024 ( 1. 004-1. 044) , 1. 002 ( 1. 000-1. 004) , 0. 946 ( 0. 909-0. 984) , 1. 473 ( 1. 180-1. 839) , 2. 135 ( 1. 232-3. 700) , all P < 0. 05) mortality in patients with HBV-ACLF and AKI. Conclusion Response to AKI treatment at 48 hours can significantly improve the short-term prognosis of patients with HBV-ACLF and AKI. Early diagnosis and active treatment of AKI should be strengthened in clinical practice to improve patient prognosis.
- liver failure /
- hepatitis B virus /
- acute kidney injury /
- treatment outcome /
- prognosis

HTML全文

参考文献(15)

[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2018) [J]. J Clin Hepatol, 2019, 35 (1) :38-44. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2018年版) [J].临床肝胆病杂志, 2019, 35 (1) :38-44.

[2] MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144 (7) :1426-1437, 1437. e1421-1429.

[3] YOU S, RONG Y, ZHU B, et al. Changing etiology of liver failure in 3, 916 patients from northern China:A 10-year survey[J]. Hepatol Int, 2013, 7 (2) :714-720.

[4] FU SJ, GAO GS, HU AR, et al. Short-term prognostic value of serum procalcitonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J]. Chin J Pract Intern Med, 2015, 35 (6) :519-521. (in Chinese) 傅叁君, 高国生, 胡爱荣, 等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志, 2015, 35 (6) :519-521.

[5] LI XP, WU ZP, ZHANG LL, et al. Advances in diagnosis and treatment of patients with acute-on-chronic liver failure complicated by acute kidney injury[J]. J Clin Hepatol, 2016, 32 (9) :1688-1693. (in Chinese) 李小鹏, 吴振平, 张伦理, 等.慢加急性肝衰竭并发急性肾损伤的诊治进展[J].临床肝胆病杂志, 2016, 32 (9) :1688-1693.

[6] HUANG Z, LIN C, FANG J, et al. Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis[J]. Hepatol Int, 2015, 9 (3) :416-423.

[7] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention andtreatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[8] ANGELI P, GINES P, WONG F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis:Revised consensus recommendations of the International Club of Ascites[J]. Gut, 2015, 64 (4) :531-537.

[9] BELCHER JM, GARCIA-TSAO G, SANYAL AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis[J]. Hepatology, 2013, 57 (2) :753-762.

[10] JIANG QQ, HAN MF, MA K, et al. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis[J]. World J Gastroenterol, 2018, 24 (21) :2300-2310.

[11] CAO D, LI DJ, WANG Y, et al. Clinical significance of CTP combined with ABIC score in predicting the short-term prognosis of patients with hepatitis B virus-related acute-onchronic fiver failure[J]. Chin J Hepatol, 2019, 27 (2) :118-122. (in Chinese) 曹丹, 李大江, 王颖, 等. CTP联合ABIC评分预测乙型肝炎相关性慢加急性肝衰竭患者短期预后的临床意义[J].中华肝脏病杂志, 2019, 27 (2) :118-122.

[12] ZHANG T, DENG CL, LI Q, et al. Value of model for endstage liver disease score combined with albumin detection in evaluating prognosis of patients with HBV-related acute-on-chronic liver failure[J]. China J Modern Med, 2019, 29 (6) :96-99. (in Chinese) 张庭, 邓存良, 李芹, 等. MELD评分体系联合ALB检测对HBV-ACLF患者预后评估的价值[J].中国现代医学杂志, 2019, 29 (6) :96-99.

[13] LI L, HU H, ZHENG XW, et al. Prediction of short-term survival by four scoring systems based on MELD in patients with acute-on-chronic hepatitis B-induced liver failure[J]. J Prac Hepatol, 2018, 21 (3) :417-420. (in Chinese) 李磊, 胡辉, 郑晓玮, 等.四种基于MELD的评分系统对慢加急性乙型肝炎肝衰竭患者短期生存的预测价值分析[J].实用肝脏病杂志, 2018, 21 (3) :417-420.

[14] SHI DM, XIANG XG, WANG XL, et al. Risk factors for incidence and prognosis of acute kidney injury in hospitalized patients with liver diseases[J]. Chin Hepatol, 2017, 22 (3) :200-204. (in Chinese) 史冬梅, 项晓刚, 王晓琳, 等.慢性肝病住院患者急性肾损伤的发病及预后相关因素分析[J].肝脏, 2017, 22 (3) :200-204.

[15] SHI X, ZHU P, YAN G, et al. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBVrelated acute-on-chronic liver failure[J]. J Viral Hepat, 2016, 23 (11) :920-929.

施引文献

资源附件(0)

访问统计